scholarly article | Q13442814 |
P2093 | author name string | Max EE | |
Burd PR | |||
Mills FC | |||
Thompson WC | |||
P2860 | cites work | Association between atopy and variants of the beta subunit of the high-affinity immunoglobulin E receptor | Q24321322 |
Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function | Q24563054 | ||
Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells | Q28237381 | ||
A family of small inducible proteins secreted by leukocytes are members of a new superfamily that includes leukocyte and fibroblast-derived inflammatory agents, growth factors, and indicators of various activation processes | Q28247742 | ||
Modulation of murine macrophage function by IL-13 | Q28505558 | ||
Recruitment of neutrophils during IgE-dependent cutaneous late phase reactions in the mouse is mast cell-dependent. Partial inhibition of the reaction with antiserum against tumor necrosis factor-alpha | Q34180375 | ||
IgE secretion by Epstein-Barr virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon gamma | Q34292243 | ||
Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor | Q34380443 | ||
Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines | Q36356540 | ||
Independent regulation of DNA recombination and immunoglobulin (Ig) secretion during isotype switching to IgG1 and IgE | Q36363224 | ||
Mast cells as a source of multifunctional cytokines | Q37781952 | ||
New insights into "the riddle of the mast cells": microenvironmental regulation of mast cell development and phenotypic heterogeneity | Q38138215 | ||
New concepts about the mast cell | Q40868020 | ||
Establishment of an immature mast cell line from a patient with mast cell leukemia | Q41296878 | ||
Release of both preformed and newly synthesized tumor necrosis factor alpha (TNF-alpha)/cachectin by mouse mast cells stimulated via the Fc epsilon RI. A mechanism for the sustained action of mast cell-derived TNF-alpha during IgE-dependent biologic | Q41677120 | ||
Clustering of cytokine genes on mouse chromosome 11. | Q41739605 | ||
Interleukin 13 is a B cell stimulating factor | Q42075980 | ||
Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin | Q42815989 | ||
Interleukin 13: novel role in direct regulation of proliferation and differentiation of primitive hematopoietic progenitor cells | Q42942429 | ||
Ig mu-epsilon isotype switch in IL-4-treated human B lymphoblastoid cells. Evidence for a sequential switch | Q44489397 | ||
Structural comparison and chromosomal localization of the human and mouse IL-13 genes. | Q48115668 | ||
Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. | Q50335911 | ||
A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors. | Q50918831 | ||
Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin. | Q54319446 | ||
The IL-4 gene maps to chromosome 11, near the gene encoding IL-3 | Q57000972 | ||
Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores | Q59052484 | ||
Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization | Q61140921 | ||
Modulation of IL-4 induced germline epsilon RNA synthesis in human B cells by tumor necrosis factor-alpha, anti-CD40 monoclonal antibodies or transforming growth factor-beta correlates with levels of IgE production | Q67534459 | ||
Localization of Evi-2 to chromosome 11: linkage to other proto-oncogene and growth factor loci using interspecific backcross mice | Q69847532 | ||
33 Polymerase chain reaction-based mRNA quantification using an internal standard: Analysis of oncogene expression | Q72083604 | ||
Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations | Q72409368 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | mast cell | Q191989 |
interleukins | Q194908 | ||
P304 | page(s) | 1373-1380 | |
P577 | publication date | 1995-04-01 | |
P1433 | published in | Journal of Experimental Medicine | Q3186912 |
P1476 | title | Activated mast cells produce interleukin 13. | |
P478 | volume | 181 |
Q28506201 | Absence of the adaptor protein Shb potentiates the T helper type 2 response in a mouse model of atopic dermatitis |
Q57492025 | Adjuvanted Immunotherapy Approaches for Peanut Allergy |
Q39187810 | Alternative activation is an innate response to injury that requires CD4+ T cells to be sustained during chronic infection |
Q78026516 | Anti VLA-4 monoclonal antibody inhibits eosinophil infiltration in allergic conjunctivitis model of guinea pig |
Q46791713 | Anti-inflammatory actions of interleukin-13: suppression of tumor necrosis factor-alpha and antigen-induced leukocyte accumulation in the guinea pig lung |
Q38183377 | Are mast cells instrumental for fibrotic diseases? |
Q73557525 | Association between elevated prolactin levels and circulating erythroid precursors in dialyzed patients |
Q35065055 | Beyond immediate hypersensitivity: evolving roles for IgE antibodies in immune homeostasis and allergic diseases |
Q34145976 | Biochemical and functional characterization of human transmembrane tryptase (TMT)/tryptase gamma. TMT is an exocytosed mast cell protease that induces airway hyperresponsiveness in vivo via an interleukin-13/interleukin-4 receptor alpha/signal trans |
Q35627845 | Biology and therapeutic potential of the interleukin-4/interleukin-13 signaling pathway in asthma |
Q64272969 | Biomaterials: Foreign Bodies or Tuners for the Immune Response? |
Q90695381 | Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma |
Q28142632 | Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activation |
Q35026770 | Chemokine production by human vascular smooth muscle cells: modulation by IL-13 |
Q40139863 | Clinical chorioamnionitis at term V: umbilical cord plasma cytokine profile in the context of a systemic maternal inflammatory response |
Q36376033 | Combined stimulation with the T helper cell type 2 cytokines interleukin (IL)-4 and IL-10 induces mouse mast cell apoptosis |
Q46494891 | Common and distinct signalling cascades in the production of tumour necrosis factor-alpha and interleukin-13 induced by lipopolysaccharide in RBL-2H3 cells |
Q41036494 | Comparative cytokine gene expression: regulation and release by human mast cells |
Q35087816 | Critical role for mast cell Stat5 activity in skin inflammation |
Q57273213 | Cultured basophils but not cultured mast cells induce human IgE synthesis in B cells after immunologic stimulation |
Q38036378 | Current concepts of IgE regulation and impact of genetic determinants. |
Q24815947 | Cytokine responses during chronic denervation |
Q43204450 | Cytokines in inflammatory bowel disease |
Q41022093 | Dexamethasone suppresses gene expression and production of IL-13 by human mast cell line and lung mast cells |
Q43867808 | Distinction between IL-13+ and IFN-gamma+ natural killer cells and regulation of their pool size by IL-4. |
Q34779773 | Effect of A2B adenosine receptor gene ablation on proinflammatory adenosine signaling in mast cells |
Q44982501 | Effector CD8+ T cells mediate inflammation and airway hyper-responsiveness |
Q37159140 | Endogenous suppression of mast cell development and survival by IL-4 and IL-10. |
Q35841251 | Enhanced mucosal permeability and nitric oxide synthase activity in jejunum of mast cell deficient mice |
Q44545289 | Epicutaneous exposure to protein antigen and food allergy |
Q39309707 | Establishment and characterization of mouse bone marrow-derived mast cell hybridomas |
Q40676990 | Expression and characterization of recombinant canine IL-13 receptor alpha2 protein and its biological activity in vitro |
Q81518455 | Expression of membrane-bound CD23 in nasal mucosal B cells from patients with perennial allergic rhinitis |
Q35155342 | Expression of surfactant protein D in airways of asthmatics and interleukin-13 modulation of surfactant protein D in human models of airway epithelium |
Q40678754 | Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene |
Q77398143 | Human mast cells produce IL-13 by high-affinity IgE receptor cross-linking: enhanced IL-13 production by IL-4-primed human mast cells |
Q43758714 | Human skin mast cells rapidly release preformed and newly generated TNF-alpha and IL-8 following stimulation with anti-IgE and other secretagogues |
Q37481155 | IL-13 but not IL-4 signaling via IL-4Rα protects mice from papilloma formation during DMBA/TPA two-step skin carcinogenesis |
Q33814921 | IL-13 in allergy: home at last |
Q60312296 | IL-13 production by allergen-stimulated T cells is increased in allergic disease and associated with IL-5 but not IFN-gamma expression |
Q51799296 | IL-13 prolongs allograft survival: association with inhibition of macrophage cytokine activation. |
Q36023579 | IL-18 stimulates IL-13-mediated IFN-gamma-sensitive host resistance in vivo |
Q36704236 | IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils |
Q51708862 | IL-4 induces characteristic Th2 responses even in the combined absence of IL-5, IL-9, and IL-13. |
Q24676901 | Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion |
Q37593712 | IgE immunotherapy: a novel concept with promise for the treatment of cancer |
Q44367209 | Immunological basis for IgE hyper-production in enfuvirtide-treated HIV- positive patients |
Q33773233 | Immunology of the cutaneous disorders of pregnancy |
Q74568880 | Immunopharmacology of human mast cells and basophils |
Q34613767 | Importance of mast cells in the pathophysiology of asthma |
Q71173525 | In vivo treatment with anti-interleukin-13 antibodies significantly reduces the humoral immune response against an oral immunogen in mice |
Q56827974 | Increased Frequencies of Allergen-Induced Interleukin-13-Producing Cells in Atopic Individuals During the Pollen Season |
Q78576690 | Increased frequency of intracellular interleukin (IL)-13 and IL-10, but not IL-4, expressing CD4+ and CD8+ peripheral T cells of patients with atopic dermatitis |
Q28386479 | Inflammasome components ASC and AIM2 modulate the acute phase of biomaterial implant-induced foreign body responses |
Q40799509 | Inhibition of keratinocyte growth in cell culture and whole skin culture by mast cell mediators. |
Q41785020 | Inhibitory effect of hot-water extract of quince (Cydonia oblonga) on immunoglobulin E-dependent late-phase immune reactions of mast cells |
Q26801604 | Innate Immunity and Biomaterials at the Nexus: Friends or Foes |
Q46042780 | Interaction between prostaglandin D and chemoattractant receptor-homologous molecule expressed on Th2 cells mediates cytokine production by Th2 lymphocytes in response to activated mast cells |
Q35931062 | Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. |
Q33997038 | Interleukin (IL)-4 and IL-13 up-regulate monocyte chemoattractant protein-1 expression in human bronchial epithelial cells: involvement of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase 1/2 and Janus kinase-2 but not c-J |
Q52049144 | Interleukin-13 is produced by activated human CD45RA+ and CD45RO+ T cells: modulation by interleukin-4 and interleukin-12. |
Q51699859 | Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9. |
Q40869698 | Interleukin-15 induces rapid tyrosine phosphorylation of STAT6 and the expression of interleukin-4 in mouse mast cells |
Q28569178 | Interleukin-25 and interleukin-13 production by alveolar macrophages in response to particles |
Q34488885 | Interleukin-4 and interleukin-13: their similarities and discrepancies |
Q31891263 | Interleukin-4-positive mast cells are highly associated with the extent of immediate allergic wheal reaction in the skin |
Q34735011 | Interleukins-4, -5, and -13: emerging therapeutic targets in allergic disease |
Q34359908 | Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression |
Q35231842 | Lactococcus lactis NCC 2287 alleviates food allergic manifestations in sensitized mice by reducing IL-13 expression specifically in the ileum |
Q39887208 | Mast cell degranulation is induced by A549 airway epithelial cell infected with respiratory syncytial virus |
Q28084141 | Mast cell production and response to IL-4 and IL-13 |
Q37538259 | Mast cells and histamine are triggering the NF-κB-mediated reactions of adult and aged perilymphatic mesenteric tissues to acute inflammation |
Q43065043 | Mast cells and the development of allergic airway disease |
Q50068970 | Mast cells as sources of cytokines, chemokines, and growth factors. |
Q40955777 | Mast cells in psoriatic skin are strongly positive for interferon-gamma |
Q43081573 | Mast cells: the forgotten cells of renal fibrosis |
Q33835029 | Mast-cell responses in the development of asthma |
Q35964610 | MicroRNA Mediated Chemokine Responses in Human Airway Smooth Muscle Cells |
Q47924558 | Mite antigen-induced IL-4 and IL-13 production by basophils derived from atopic asthma patients |
Q33731233 | Modulation of exaggerated-IgE allergic responses by gene transfer-mediated antagonism of IL-13 and IL-17e |
Q70911242 | Modulation of expression of the anti-inflammatory cytokines interleukin-13 and interleukin-10 by interleukin-3 |
Q36354729 | Molecular aspects of regulation of collagen gene expression in fibrosis. |
Q40801501 | Molecular cloning of canine IL-13 receptor alpha chain (alpha1 and alpha2) cDNAs and detection of corresponding mRNAs in canine tissues |
Q36033294 | Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis |
Q40546819 | Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1beta |
Q37900132 | Morphea developing at the site of healed herpes zoster |
Q35376176 | Mountain cedar pollen induces IgE-independent mast cell degranulation, IL-4 production, and intracellular reactive oxygen species generation |
Q58478781 | Mouse macrophage development in the absence of the common γ chain: defining receptor complexes responsible for IL-4 and IL-13 signaling |
Q41199705 | Mucosal allergy: role of mast cells and eosinophil granulocytes in the gut. |
Q37013193 | Network-guided sparse regression modeling for detection of gene-by-gene interactions |
Q43227973 | Overexpression of IL-13 in patients with bladder cancer. |
Q39865005 | Overexpression of interleukin-13 in a murine T-cell lymphoma: a possible factor of DL-induced immunosuppression and tumor progression |
Q52723837 | PAI1 mediates fibroblast-mast cell interactions in skin fibrosis. |
Q35090733 | Pharmacological modulation of human mast cells and basophils |
Q41068693 | Production of interleukin 13 by alveolar macrophages from normal and fibrotic lung |
Q41219255 | Prospects for the immunological control of ruminant gastrointestinal nematodes: natural immunity, can it be harnessed? |
Q61960815 | Purified human peripheral blood basophils release interleukin-13 and preformed interleukin-4 following immunological activation |
Q28365236 | Rat mast cell protease-I enhances immunoglobulin E production by mouse B cells stimulated with interleukin-4 |
Q52591788 | Recombinant canine IL-13 receptor alpha2-Fc fusion protein inhibits canine allergen-specific-IgE production in vitro by peripheral blood mononuclear cells from allergic dogs. |
Q40774154 | Regulation of IL-13 production by histamine in cloned murine T helper type 2 cells |
Q34126154 | Regulation of T helper type 2 cell immunity by interleukin-4 and interleukin-13. |
Q40379377 | Regulatory effects of cytokine production in atopic allergic reaction by gammi-danguieumja |
Q28246659 | Requirement for leukotriene B4 receptor 1 in allergen-induced airway hyperresponsiveness |
Q36438370 | Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice |
Q35207665 | Rhinovirus infection induces interleukin-13 production from CD11b-positive, M2-polarized exudative macrophages |
Q92733040 | Role of Leukotriene B4 Receptor-2 in Mast Cells in Allergic Airway Inflammation |
Q36287476 | Role of human mast cells and basophils in bronchial asthma |
Q45044608 | Secretion of interleukin-1 receptor antagonist from human mast cells after immunoglobulin E-mediated activation and after segmental antigen challenge |
Q42944667 | Simultaneous disruption of interleukin (IL)-4 and IL-13 defines individual roles in T helper cell type 2-mediated responses |
Q77419325 | Surface and gene expression of immunoglobulin E receptors on mast cells and mast-cell numbers in interleukin-4-gene knockout mice |
Q47746694 | Temporal regulation of cytokine mRNA expression in equine recurrent airway obstruction |
Q43204186 | Th2 cells and cytokine networks in allergic inflammation of the lung |
Q40048581 | The Diacylglycerol-dependent translocation of ras guanine nucleotide-releasing protein 4 inside a human mast cell line results in substantial phenotypic changes, including expression of interleukin 13 receptor alpha2. |
Q92187895 | The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma |
Q47346396 | The expression of stem cell factor and c-kit receptor in human asthmatic airways |
Q38351114 | The expression, regulation and adhesion function of a novel CD molecule, CD226, on human endothelial cells |
Q33977232 | The pathology of chronic asthma |
Q91797911 | The role of HOTAIR-induced downregulation of microRNA-126 and interleukin-13 in the development of bronchial hyperresponsiveness in neonates |
Q33711407 | The role of IL-13 in helminth-induced inflammation and protective immunity against nematode infections. |
Q28216638 | The role of interleukin 13 in classical Hodgkin lymphoma |
Q24795598 | Titanium dioxide particle-induced goblet cell hyperplasia: association with mast cells and IL-13 |
Q33602537 | Transcription factor GATA1 is dispensable for mast cell differentiation in adult mice |
Q43987760 | Transient contribution of mast cells to pulmonary eosinophilia but not to hyper-responsiveness |
Q92066717 | Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches |
Search more.